Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

China Health Group Inc. (VNL1) AI Stock Analysis

0 Followers
DE:VNL1

China Health Group Inc.

(Frankfurt:VNL1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
No reported debtThe absence of reported debt limits interest obligations and refinancing exposure, giving the company greater financial flexibility than a highly leveraged peer. This cushion can help preserve resources for operations and investment even while profitability remains weak.
Negative Factors
Persistent net lossesMulti-year losses indicate that the business has not yet demonstrated a sustainable earnings model. A TTM net margin near -52% means revenue is currently insufficient to cover the full cost base, limiting reinvestment capacity and increasing pressure on the capital base.

China Health Group Inc. (VNL1) vs. iShares MSCI Germany ETF (EWG)

-80%-60%-40%-20%0%20%DE:VNL1-43.33%EWG+6.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 6.88M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-2.4
Beta (1Y)
-13.94
Revenue Growth
-2.02%
EPS Growth
0.00%
Country
Germany
Employees
33
Sector
Healthcare
Sector Strength
51
Industry
Medical - Pharmaceuticals

China Health Group Inc. Business Overview & Revenue Model

Company Description

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, an...

China Health Group Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:VNL1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:2359HK:235975OutperformHKD 530.80B16.3830.77%1.19%38.26%84.56%
HK:6127HK:612772OutperformHKD 37.05B29.7813.10%0.57%16.68%442.43%
HK:3347HK:334755NeutralHKD 42.53B-101.89-2.00%0.38%21.72%-169.67%
HK:6667HK:666754NeutralHKD 1.45B47.724.04%2.55%169.02%-24.61%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%200%400%DE:VNL1HK:3347HK:2359HK:6127HK:6667HK:8247Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:VNL1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:VNL1China Health Group Inc.0.02-0.01-43.33%
HK:3347Hangzhou Tigermed Consulting Co., Ltd. Class H38.04-5.91-13.45%
HK:2359WuXi AppTec Co., Ltd. Class H201.4097.8794.53%
HK:6127JOINN Laboratories (China) Co., Ltd. Class H24.405.1226.58%
HK:6667Mega Genomics Limited6.67-0.36-5.08%
HK:8247Biosino Bio-Technology & Science, Inc. Class H2.351.32128.16%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.